Estepan Ian Michael
SEC CIK 1836254 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | COO | 177.2K | — | $1.27M | 34 | 2021-09-08 | 2026-09-04 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 20:03 | 2026-09-04 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | F - Tax | $22.22 | -24.8K | 177.2K | -12% | -$551.0K | |
| 2026-03-13 | 2026-03-11 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | F - Tax | $17.03 | -1,097 | 202.0K | -0.5% | -$18.7K | |
| M | 2026-03-11 | 2026-03-09 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | F - Tax | $16.95 | -1,619 | 203.1K | -0.8% | -$27.4K |
| DM | 2026-03-03 | 2026-03-02 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | F - Tax | $16.20 | -4,176 | 205.6K | -2% | -$67.7K |
| D | 2026-03-03 | 2026-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | M - OptEx | — | +8,125 | 208.9K | +4% | — |
| DM | 2026-03-02 | 2026-02-26 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | M - OptEx | $13.71 | +7,450 | 200.8K | +4% | +$102.1K |
| 2025-12-18 | 2025-12-16 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | S - Sale | $22.31 | -13.2K | 193.3K | -6% | -$294.2K | |
| M | 2025-09-05 | 2025-09-03 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | COO | A - Grant | $0.00 | +143.9K | 156.5K | +1,141% | $0 |
| D | 2025-03-11 | 2025-03-07 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | M - OptEx | — | +5,500 | 58.3K | +10% | — |
| DM | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $100.13 | -3,941 | 54.3K | -7% | -$394.6K |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | A - Grant | — | +8,276 | 62.6K | +15% | — |
| DM | 2025-03-10 | 2025-03-07 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $103.70 | -9,679 | 52.8K | -15% | -$1.00M |
| D | 2025-03-10 | 2025-03-06 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | M - OptEx | — | +17.5K | 62.5K | +39% | — |
| 2025-03-06 | 2025-03-04 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $101.34 | -1,370 | 45.0K | -3% | -$138.8K | |
| 2025-03-04 | 2025-03-03 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $103.77 | -557 | 46.3K | -1% | -$57.8K | |
| DM | 2025-01-31 | 2025-01-29 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | M - OptEx | $12.00 | +15.8K | 49.5K | +47% | +$189.6K |
| D | 2025-01-31 | 2025-01-29 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $117.51 | -2,613 | 46.9K | -5% | -$307.1K |
| 2024-12-30 | 2024-12-27 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | G - Gift | $0.00 | -250 | 33.7K | -0.7% | $0 | |
| 2024-09-03 | 2024-08-30 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | S - Sale | $137.36 | -5,985 | 33.9K | -15% | -$822.1K | |
| D | 2024-06-25 | 2024-06-24 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $164.64 | -2,483 | 39.9K | -6% | -$408.8K |
| D | 2024-06-25 | 2024-06-21 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | M - OptEx | — | +6,250 | 42.4K | +17% | — |
| M | 2024-03-11 | 2024-03-07+ | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $122.25 | -1,561 | 36.2K | -4% | -$190.8K |
| 2024-03-06 | 2024-03-04 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $125.32 | -1,389 | 37.7K | -4% | -$174.1K | |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | A - Grant | $0.00 | +6,000 | 40.3K | +17% | $0 |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | S - Sale | $128.30 | -1,200 | 39.1K | -3% | -$154.0K |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $126.19 | -365 | 34.3K | -1% | -$46.1K |
| 2023-03-10 | 2023-03-08 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $153.19 | -744 | 34.7K | -2% | -$114.0K | |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | A - Grant | $0.00 | +4,500 | 35.4K | +15% | $0 |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $157.21 | -1,370 | 30.9K | -4% | -$215.4K |
| 2023-03-03 | 2023-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $147.57 | -378 | 32.3K | -1% | -$55.8K | |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | A - Grant | $0.00 | +8,000 | 32.7K | +32% | $0 |
| DM | 2022-03-08 | 2022-03-04+ | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $79.24 | -1,706 | 25.1K | -6% | -$135.2K |
| 2022-03-01 | 2022-03-01 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $75.05 | -376 | 26.4K | -1% | -$28.2K | |
| 2021-09-09 | 2021-09-08 | SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | CFO | F - Tax | $78.29 | -1,623 | 26.8K | -6% | -$127.1K |
Purchase Sale Sale after option exercise All abbreviations